Taipei, Taiwan

Hsiang-Ling Su

USPTO Granted Patents = 5 

 

Average Co-Inventor Count = 2.7

ph-index = 1

Forward Citations = 2(Granted Patents)


Company Filing History:


Years Active: 2016-2018

Loading Chart...
Loading Chart...
5 patents (USPTO):Explore Patents

Title: Hsiang-Ling Su: Innovator in Skin Health Solutions

Introduction

Hsiang-Ling Su is a prominent inventor based in Taipei, Taiwan. He has made significant contributions to the field of skin health through his innovative patents. With a total of five patents to his name, Su is recognized for his work in developing methods that enhance skin healing and promote overall skin health.

Latest Patents

One of Hsiang-Ling Su's latest patents is a method for inhibiting melanogenesis and promoting collagen production and wound healing. This invention provides a method that involves administering an effective amount of a specific compound to inhibit melanin formation, promote collagen production, and facilitate wound repair. The compound can be utilized to manufacture compositions aimed at skin whitening, anti-aging, and wound healing. Another notable patent involves peptides that promote wound healing, collagen production, and angiogenesis. These peptides possess anti-viral and antibacterial properties, which help reduce infections and promote tissue recovery.

Career Highlights

Hsiang-Ling Su is currently associated with Tci Co., Ltd., where he continues to innovate in the field of skin health. His work has garnered attention for its potential applications in health care products aimed at enhancing recovery and immunity.

Collaborations

Su collaborates with talented individuals such as Yung-Hsiang Lin and Chin-Hsiu Yu, contributing to a dynamic research environment that fosters innovation.

Conclusion

Hsiang-Ling Su's contributions to skin health through his innovative patents highlight his role as a leading inventor in the field. His work not only addresses critical health issues but also paves the way for future advancements in skin care solutions.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…